Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangli Ma

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 15, 2026
Safety, Pharmacokinetics, and Pharmacodynamics of GS1-144, a Neurokinin-3 Receptor Antagonist: A Randomized Phase 1 Single and Multiple Ascending Dose and Food Effect StudyXiaojie Wu, Jingjing Wang, Xinyi Yang, et al.
Journal of Cancer Research and Therapeutics|October 11, 2016
Aidi injection combined with CHOP chemotherapy regimen in the treatment of malignant lymphoma: A meta-analysis based on randomized controlled trialsXiaoli Wang, Weimei Jin, Bingmu Fang, et al.
Mabs|February 5, 2026
Dual agonism and selective T-cell depletion activity of a PD-1-directed antibody for treating autoimmune diseasesWenbo Jiang, Lingyun Li, Weili Xue, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 15, 2026
Safety, Pharmacokinetics, and Pharmacodynamics of GS1-144, a Neurokinin-3 Receptor Antagonist: A Randomized Phase 1 Single and Multiple Ascending Dose and Food Effect StudyXiaojie Wu, Jingjing Wang, Xinyi Yang, et al.
Journal of Cancer Research and Therapeutics|October 11, 2016
Aidi injection combined with CHOP chemotherapy regimen in the treatment of malignant lymphoma: A meta-analysis based on randomized controlled trialsXiaoli Wang, Weimei Jin, Bingmu Fang, et al.
Mabs|February 5, 2026
Dual agonism and selective T-cell depletion activity of a PD-1-directed antibody for treating autoimmune diseasesWenbo Jiang, Lingyun Li, Weili Xue, et al.
Pageof 2